Clinical Trials Browser

Phase 2 × Anxiety Disorders × Clear all

NCT07336238 2026-04-17

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Phase 2 Recruiting

Anxiety Disorders, Depression, Neoplasm Metastasis

NCT06200155 2026-04-16

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

Phase 2 Recruiting

Anxiety Disorders, Depression

NCT06801041 2026-04-16

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

Phase 2 Recruiting

Anxiety Disorders, Depression, Neoplasms

NCT07174947 2026-03-24

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

Phase 2 Recruiting

Anxiety Disorders

NCT07002034 2026-03-16

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Phase 2 Recruiting

Adjustment Disorders, Amyotrophic Lateral Sclerosis, Anxiety Disorders, Depression, Multiple Sclerosis, Neoplasms, Idiopathic Pulmonary Fibrosis

NCT04301089 2026-03-11

Immersive Virtual Reality (VR) at the Time of Clinical Evaluation to Improve Psychological Distress and Anxiety in Primary Brain Tumor (PBT) Patients

Phase 2 Completed

61 enrolled 20 charts

Anxiety Disorders, Brain Neoplasms

NCT03948074 2025-09-10

CAFCARS

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

NCT06266611 2025-08-01

ARCTiC

Phase 2 Recruiting

Anxiety Disorders, Depression, Pain

NCT04482244 2025-07-29

RCT of CBD for Anxiety in Advanced Breast Cancer

Phase 2 Active not recruiting

60 enrolled 11 charts

Anxiety Disorders

NCT06081348 2025-07-16

CALM

Phase 2 Recruiting

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders

NCT04513444 2025-04-04

HYPNOMUSE

Phase 2 Recruiting

Anxiety Disorders

NCT02203552 2025-01-08

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Phase 2 Completed

56 enrolled 9 charts

Anxiety Disorders, Breast Neoplasms, Depression

NCT05981924 2024-07-17

Perioperative Music Therapy Plus Oxycodone in Perioperative Management of Lung Surgery

Phase 2 Completed

Agnosia, Anxiety Disorders, Lung Neoplasms

NCT06435104 2024-07-09

Aromatherapy in the Treatment of Early Breast Cancer

Phase 2 Not yet recruiting

Anxiety Disorders, Breast Neoplasms

NCT00979693 2023-12-26

Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma

Phase 2 Withdrawn

Anxiety Disorders, Depression, Melanoma, Pain

NCT03944447 2022-06-02

OMNI-Can

Phase 2 Unknown

200,000 enrolled

Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

NCT01466270 2021-10-20

Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

Phase 2 Completed

62 enrolled 12 charts

Anxiety Disorders, Breast Neoplasms, Cognition Disorders, Depression, Fatigue, Sleep Wake Disorders

NCT00465595 2018-07-19

Psychopharmacology of Psilocybin in Cancer Patients

Phase 2 Completed

56 enrolled 8 charts

Anxiety Disorders, Depression, Neoplasms

NCT00252174 2017-11-14

MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer

Phase 2 Terminated

2 enrolled 6 charts

Anxiety Disorders, Neoplasms

NCT03063931 2017-02-27

Pain and Magnesium

Phase 2 Unknown

Anxiety Disorders, Breast Neoplasms, Depression, Pain

NCT02600299 2016-09-22

Effectiveness of a Psycho-educational Group (PEG) Intervention on Supportive Care and Survivorship Issues in Early-stage Breast Cancer Survivors Who Have Received Systemic Treatment

Phase 2 Completed

Anxiety Disorders, Breast Neoplasms, Neoplasms, Cognitive Dysfunction

NCT00005850 2016-07-04

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Phase 2 Completed

Adenocarcinoma of Lung, Anxiety Disorders, Carcinoma, Non-Small-Cell Lung, Depression, Fatigue, Lung Neoplasms

NCT01680172 2016-02-29

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Phase 2 Terminated

5 enrolled 6 charts

Anxiety Disorders, Depression, Neoplasms

NCT02468050 2015-06-10

Study of Exercise to Manage Distress During Breast Screening

Phase 2 Completed

Anxiety Disorders, Breast Neoplasms, Depression, Disease, Motor Activity

NCT01510236 2015-05-28

U-CARE:TeenCan

Phase 2 Withdrawn

Anxiety Disorders, Depression, Neoplasms

NCT01519895 2015-04-15

Effectiveness of Telephone Intervention for Colorectal Cancer Caregivers

Phase 2 Completed

Gastrointestinal

Anxiety Disorders, Colonic Neoplasms, Stress, Psychological

NCT00706290 2014-06-06

Brief CBT for Anxiety and Advanced Cancer

Phase 2 Completed

Anxiety Disorders, Depression, Neoplasm Metastasis, Neoplasms

NCT00122369 2013-02-28

Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy

Phase 2 Completed

240 enrolled 32 charts

Anxiety Disorders, Breast Neoplasms, Pain

NCT00583739 2008-12-04

Yoga to Reduce Cancer Fatigue

Phase 2 Completed

Anxiety Disorders, Breast Neoplasms, Fatigue

NCT00774813 2008-10-17

Nexalin Therapy for the Treatment of Depressive Symptoms

Phase 2 Completed

Anxiety Disorders, Depression, Lymphoma, Follicular

NCT00004310 2005-06-24

Phase II Randomized Study of Intravenous Versus Oral Clomipramine in Patients With Obsessive Compulsive Disorder

Phase 2 Unknown

Anxiety Disorders, Mental Disorders, Neurologic Manifestations, Obsessive-Compulsive Disorder, Rare Diseases